source
- Dren Bio secures $350 million to advance blood-cancer therapy toward 2027 launchDren Bio, a California biotech firm, announced it has closed a financing round that raised $350 million. The funding will be directed toward developing its lead blood‑cancer drug, with the company…
- Eli Lilly consolidates US and international sales under new global markets unit as veteran exec retiresEli Lilly announced that long‑time executive Patrik Jonsson will retire after 36 years with the company. Jonsson has been serving as executive vice president and president of Lilly International, o…